The percentage of CD4+Foxp3+ Tregs showed an increasing trend; however, the increase was not statistically significant.
← all excerpts
CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
1
—
—